Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 70/100

Failure Rate

62.5%

5 terminated/withdrawn out of 8 trials

Success Rate

37.5%

-49.0% vs industry average

Late-Stage Pipeline

25%

2 trials in Phase 3/4

Results Transparency

267%

8 of 3 completed trials have results

Key Signals

8 with results

Enrollment Performance

Analytics

N/A

4(50.0%)

Phase 2

2(25.0%)

Phase 4

2(25.0%)

8Total

N/A(4)

Phase 2(2)

Phase 4(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (8)

Showing 8 of 8 trials

NCT02388880Not ApplicableTerminated

Effect of Intrathoracic Pressure Regulation on Decreased Cerebral Perfusion (4hour)

Role: lead

NCT00189423Not ApplicableTerminated

ResQ Trial: Impact of an ITD and Active Compression Decompression CPR on Survival From Out-of-Hospital Cardiac Arrest

Role: lead

NCT01824576Not ApplicableTerminated

Effect of Intrathoracic Pressure Regulation on Decreased Cerebral Perfusion

Role: lead

NCT01325870Not ApplicableCompleted

Hemodynamic Effects of Standard Cardiopulmonary Resuscitation (CPR), Active Compression Decompression CPR With an Inspiratory Impedance Device, and Standard CPR With an Intrathoracic Pressure Regulator During Out-of-hospital Cardiac Arrest

Role: lead

NCT01780350Phase 4Completed

Assessment of the Implementation of the ResQGARD® Impedance Threshold Device by the San Antonio Fire Department

Role: lead

NCT01824589Phase 4Terminated

Effect of Intrathoracic Pressure Regulation on Traumatic Brain Injury

Role: lead

NCT00256724Phase 2Completed

Efficacy Study of a Facemask Device to Treat Hypotension

Role: lead

NCT00576524Phase 2Terminated

Application of Impedance Threshold Device Technologies to Treat and Prevent Hypotension During Dialysis

Role: collaborator

All 8 trials loaded